Innate immune signals and p53 contribute to the 5q– myelodysplastic syndrome, an acquired bone marrow failure disorder (pages 49–58 and 59–66).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rollison, D.E. et al. Blood 122, 45 (2008).
Barlow, J. et al. Nat. Med. 16, 59–66 (2010).
Starczynowski, D.T. et al. Nat. Med. 16, 49–58 (2010).
Van den Berghe, H. et al. Nature 251, 437–438 (1974).
Ebert, B.L. et al. Nature 451, 335–339 (2008).
Pellagatti, A. et al. Br. J. Haematol. 142, 57–64 (2008).
Danilova, N., Sakamoto, K.M. & Lin, S. Blood 112, 5228–5237 (2008).
McGowan, K.A. et al. Nat. Genet. 40, 963–970 (2008).
Gazda, H.T. & Sieff, C.A. Br. J. Haematol. 135, 149–157 (2006).
Liu, Y. et al. Cell Stem Cell 4, 37–48 (2009).
Akala, O.O. et al. Nature 453, 228–232 (2008).
Gangaraju, V.K. & Lin, H. Nat. Rev. Mol. Cell Biol. 10, 116–125 (2009).
List, A. et al. N. Engl. J. Med. 355, 1456–1465 (2006).
Jadersten, M. et al. Haematologica 94, 1762–1766 (2009).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, Y., Asai, T. & Nimer, S. Myelodysplasia: battle in the bone marrow. Nat Med 16, 30–32 (2010). https://doi.org/10.1038/nm0110-30
Issue Date:
DOI: https://doi.org/10.1038/nm0110-30
This article is cited by
-
(2S,4R)-4-[18F]Fluoroglutamine as a PET Indicator for Bone Marrow Metabolism Dysfunctional: from Animal Experiments to Clinical Application
Molecular Imaging and Biology (2019)
-
Clonal origin and evolution of myelodysplastic syndrome analyzed by dysplastic morphology and fluorescence in situ hybridization
International Journal of Hematology (2015)